Register entry

Polpharma Biologics S.A.

Data as of · How to read this entry

Registered sites
2
Active NDC listings
1
Live patents
0
Countries
1
Base
Poland
Authorisation

Registered operations

Analytical testing2Active ingredient (API) manufacture2
Sites

Registered establishments

2
EstablishmentAddressRegistered forFEI / DUNS
Polpharma Biologics S.A.Ul. Spoldzielcza 4, Duchnice, Ozarow Mazowiecki 05-850, Poland (POL)Analytical testing, Active ingredient (API) manufacture3027094019849736088
Polpharma Biologics S.A.ul. Trzy Lipy 3, Gdansk, 80-172, Poland (POL)Analytical testing, Active ingredient (API) manufacture3013195136850663938
Catalogue

Marketed products

1
BrandGeneric nameForm / routeNDC
-ranibizumabsolution, concentrate82775-100BULK INGREDIENT
Compare

Comparable companies in Poland

Enquiry

Common questions

Is Polpharma Biologics S.A. FDA approved?
Polpharma Biologics S.A. holds 2 FDA-registered establishments in Poland. Registration puts a site on the FDA's register and open to inspection; it is not an approval of the company. Approvals attach to individual drug applications.
Where are Polpharma Biologics S.A.'s drugs manufactured?
The FDA register lists Duchnice; Gdansk. Registered operations: analytical testing, active ingredient (API) manufacture.
What drugs does Polpharma Biologics S.A. make?
1 product is listed under Polpharma Biologics S.A. in the openFDA NDC Directory, most often as solution, concentrate. The full breakdown by dosage form and route is above. A listing count is not a sales figure.

Compiled from FDA establishment registrations, the openFDA NDC Directory, the Orange Book and the FDA drug shortage database. Not claimed by the company. Sources and methodology.